You always lose the essential item, Leronlimab has been tested in over 700 patients and he is well known to the FDA.
Most of these drugs that were approved after 100 patients treated did not undergo long-term testing that passed Leronlimab.

If Leronlimab is near effective as in mice, it will be very quickly approved for cancers.